See more : Technical Communications Corporation (TCCO) Income Statement Analysis – Financial Results
Complete financial analysis of TriplePoint Venture Growth BDC Corp. (TPVG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TriplePoint Venture Growth BDC Corp., a leading company in the Asset Management industry within the Financial Services sector.
- AVTECH Sweden AB (publ) (AVT-B.ST) Income Statement Analysis – Financial Results
- HAVN Life Sciences Inc. (HAVLF) Income Statement Analysis – Financial Results
- Plymouth Rock Technologies Inc. (PLRTF) Income Statement Analysis – Financial Results
- SaltX Technology Holding AB (publ) (SALT-B.ST) Income Statement Analysis – Financial Results
- IG Group Holdings plc (IGGHY) Income Statement Analysis – Financial Results
TriplePoint Venture Growth BDC Corp. (TPVG)
About TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 61.73M | 119.42M | 83.37M | 42.00M | 40.20M | 41.53M | 24.64M | 15.59M | 22.54M | 29.94M |
Cost of Revenue | -75.76M | 24.66M | 24.79M | 23.26M | 18.47M | 15.62M | 13.29M | 9.85M | 11.01M | 0.00 |
Gross Profit | 137.49M | 94.76M | 58.58M | 18.74M | 21.73M | 25.91M | 11.35M | 5.74M | 11.53M | 29.94M |
Gross Profit Ratio | 222.74% | 79.35% | 70.26% | 44.62% | 54.05% | 62.40% | 46.08% | 36.81% | 51.15% | 100.00% |
Research & Development | 0.00 | -0.27 | 1.14 | 0.35 | 0.44 | 0.55 | 0.37 | 0.49 | 0.00 | 0.00 |
General & Administrative | 9.00M | 6.70M | 6.13M | 6.70M | 6.04M | 4.96M | 4.30M | 4.47M | 4.35M | 10.37M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 9.00M | 6.70M | 6.13M | 6.70M | 6.04M | 4.96M | 4.30M | 4.47M | 4.35M | 10.37M |
Other Expenses | -36.07M | 51.42M | 681.00K | 38.76M | 2.40M | 2.55M | 3.63M | 2.58M | 2.67M | 0.00 |
Operating Expenses | -27.07M | 6.70M | 6.81M | 6.70M | 8.44M | 4.96M | 5.41M | 4.47M | 7.02M | 8.12M |
Cost & Expenses | -27.07M | 55.87M | 6.81M | 6.70M | 8.44M | 18.54M | 16.18M | 12.77M | 14.14M | 8.12M |
Interest Income | 133.25M | 116.57M | 82.83M | 88.57M | 70.52M | 62.61M | 50.04M | 41.77M | 39.90M | 4.68M |
Interest Expense | 33.04M | 26.76M | 17.37M | 15.49M | 10.01M | 9.08M | 9.06M | 7.86M | 3.62M | 0.00 |
Depreciation & Amortization | 0.00 | 66.73M | -27.22M | 48.93M | 28.60M | 29.75M | 31.01M | 11.79M | -2.82M | -20.05M |
EBITDA | 0.00 | 0.00 | 0.00 | -12.55M | -6.50M | 45.64M | 28.29M | 18.99M | 19.14M | -5.76M |
EBITDA Ratio | 0.00% | 68.61% | 91.83% | 84.06% | 79.00% | 103.78% | 104.60% | 105.25% | 84.92% | -9.67% |
Operating Income | 73.81M | 90.32M | 76.56M | 35.31M | 31.76M | 34.99M | 26.27M | 23.01M | 21.96M | 20.05M |
Operating Income Ratio | 119.57% | 75.63% | 91.83% | 84.06% | 79.00% | 84.26% | 106.60% | 147.59% | 97.43% | 66.95% |
Total Other Income/Expenses | -113.63M | -62.13M | -3.06M | 23.26M | -14.09M | 1.57M | -7.04M | -11.89M | 0.00 | -5.28M |
Income Before Tax | -39.82M | -20.07M | 76.56M | 35.31M | 31.76M | 36.56M | 19.23M | 11.13M | 15.52M | 17.15M |
Income Before Tax Ratio | -64.51% | -16.81% | 91.83% | 84.06% | 79.00% | 88.05% | 78.03% | 71.36% | 68.87% | 57.28% |
Income Tax Expense | 0.00 | 26.76M | 40.42M | 47.85M | 38.25M | 7.95M | 29.40M | 18.99M | 296.00K | -2.90M |
Net Income | -39.82M | -46.83M | 76.56M | 35.31M | 31.76M | 36.56M | 19.23M | 11.13M | 15.52M | 17.15M |
Net Income Ratio | -64.51% | -39.21% | 91.83% | 84.06% | 79.00% | 88.05% | 78.03% | 71.36% | 68.87% | 57.28% |
EPS | -1.12 | -1.43 | 2.47 | 1.16 | 1.28 | 1.78 | 1.18 | 0.69 | 1.03 | 1.74 |
EPS Diluted | -1.12 | -1.43 | 2.47 | 1.16 | 1.28 | 1.78 | 1.18 | 0.69 | 1.03 | 1.74 |
Weighted Avg Shares Out | 35.71M | 32.69M | 30.94M | 30.57M | 24.84M | 20.49M | 16.32M | 16.16M | 15.04M | 9.87M |
Weighted Avg Shares Out (Dil) | 35.71M | 32.69M | 30.94M | 30.57M | 24.84M | 20.49M | 16.32M | 16.16M | 15.04M | 9.87M |
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Triplepoint Investors of a Lead Plaintiff Deadline of August 15, 2023
FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in TriplePoint Venture Growth BDC Corp. with Losses of $100,000 to Contact the Firm
TriplePoint Venture Growth: I Am Aggressively Jumping On This 14% BDC Yield
TPVG SHAREHOLDER ALERT: Jakubowitz Law Reminds Triplepoint Shareholders of a Lead Plaintiff Deadline of August 15, 2023
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment TriplePoint Venture Growth BDC Corp. - TPVG
TPVG LAWSUIT ALERT: Levi & Korsinsky Notifies Triplepoint Venture Growth BDC Corp. Investors of a Class Action Lawsuit and Upcoming Deadline
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Triplepoint Venture Growth BDC Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 15, 2023 - (NYSE: TPVG)
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in TriplePoint Venture Growth BDC Corp. with Losses of $100,000 to Contact the Firm
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in TriplePoint Venture Growth BDC Corp. with Losses of $100,000 to Contact the Firm
TPVG ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 15, 2023 in the Class Action Filed on Behalf of Triplepoint Venture Growth BDC Corp. Shareholders
Source: https://incomestatements.info
Category: Stock Reports